05:10 PM EDT, 06/25/2024 (MT Newswires) -- Dana Pizzuti, Chief Medical and Development Officer, on June 24, 2024, sold 9,500 shares in Crinetics Pharmaceuticals ( CRNX ) for $434,435. Following the Form 4 filing with the SEC, Pizzuti has control over a total of 27,786 shares of the company, with 27,786 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000095017024077402/xslF345X03/ownership.xml